Mini-Review
A tumor intrinsic role of CD73 in pancreatic adenocarcinoma
Annals of Pancreatic Cancer
2022;
5:
9
(31 October 2022)
Editorial Commentary
From pancreatic cancer to lung cancer, ZIP4’s oncogenic function continues
Annals of Pancreatic Cancer
2022;
5:
8
(30 July 2022)
Editorial Commentary
“RHAMM knockout” mice express a truncated RHAMM protein that promotes pancreatic cancer progression with dysfunctional p53
Annals of Pancreatic Cancer
2022;
5:
7
(10 July 2022)
Case Report
Transformation of metastatic nonfunctioning pancreatic neuroendocrine tumor into insulinoma—two case reports
Annals of Pancreatic Cancer
2022;
5:
6
(21 June 2022)
Case Report
Pancreatic neuroendocrine tumor in a 27-year-old patient with Cornelia de Lange syndrome: a case report
Annals of Pancreatic Cancer
2022;
5:
5
(30 May 2022)
Original Article
EBF2 contributes to pancreatic cancer progenitor cell differentiation and tumor suppression
Annals of Pancreatic Cancer
2022;
5:
4
(10 April 2022)
Review Article
Drain and nasogastric tube use following pancreatoduodenectomy: a narrative review
Annals of Pancreatic Cancer
2022;
5:
3
(31 March 2022)
Review Article
Selected intra-operative factors which affect pancreaticoduodenectomy outcomes: a narrative review
Annals of Pancreatic Cancer
2022;
5:
2
(31 March 2022)
Original Article
Blood transfusion is associated with worse outcomes following pancreatic resection for pancreatic adenocarcinoma
Annals of Pancreatic Cancer
2022;
5:
1
(31 March 2022)
Review Article
Selected pre-operative factors which affect pancreaticoduodenectomy outcomes: a systematic review
Annals of Pancreatic Cancer
2021;
4:
10
(10 November 2021)
Case Report
Case series: FDG-avid lymphadenopathy during oncologic staging of pancreatic adenocarcinoma after COVID-19 vaccination
Annals of Pancreatic Cancer
2021;
4:
9
(30 October 2021)
Review Article
The robotic central pancreatectomy: surgical technique, and literature review
Annals of Pancreatic Cancer
2021;
4:
8
(30 October 2021)
Original Article
A single-institutional analysis of racial disparities in clinicopathologic characteristics, treatment selections, and outcomes in advanced-stage pancreatic cancer patients
Annals of Pancreatic Cancer
2021;
4:
7
(30 October 2021)
Original Article
Pancreatic adenocarcinoma in liver transplant recipients: a case series
Annals of Pancreatic Cancer
2021;
4:
6
(30 October 2021)
Review Article
Solid pseudopapillary neoplasm of the pancreas: cytomorphology, pitfalls, and literature review
Annals of Pancreatic Cancer
2021;
4:
5
(30 July 2021)
Review Article
Volatile organic compound analysis for the diagnosis of pancreatic cancer
Annals of Pancreatic Cancer
2021;
4:
4
(30 July 2021)
Original Article
A national database analysis of acinar cell carcinoma of the pancreas, a histologically, epidemiologically, and biologically distinct entity increasing in incidence
Annals of Pancreatic Cancer
2021;
4:
3
(30 July 2021)
Original Article
A Phase 1b clinical trial of LDE225 (Sonidegib) in combination with fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFIRINOX) in previously untreated locally advanced or metastatic pancreatic adenocarcinoma
Annals of Pancreatic Cancer
2021;
4:
2
(30 July 2021)
Original Article
Association of germline ATM mutations and survival in pancreatic cancer
Annals of Pancreatic Cancer
2021;
4:
1
(30 July 2021)
Review Article
Modeling human pancreatic ductal adenocarcinoma for translational research: current options, challenges, and prospective directions
Annals of Pancreatic Cancer
2020;
3:
17
(29 December 2020)
Original Article
MRI screening in hereditary pancreatic cancer: value of various sequences in the detection of early pancreatic cancer
Annals of Pancreatic Cancer
2020;
3:
16
(30 November 2020)
Original Article
Quantitative metric for assessment of pancreatic ductal adenocarcinoma treatment response in T1-weighted gadolinium-enhanced magnetic resonance imaging
Annals of Pancreatic Cancer
2020;
3:
15
(25 November 2020)
Case Report
Primary squamous cell carcinoma of the pancreas: case report and literature review
Annals of Pancreatic Cancer
2020;
3:
14
(23 November 2020)
Original Article
Fluoropyrimidine-based maintenance chemotherapy after FOLFIRINOX for patients with metastatic pancreatic adenocarcinoma: a retrospective analysis
Annals of Pancreatic Cancer
2020;
3:
13
(10 November 2020)
Original Article
Predictive factors of improved postoperative outcomes in pancreatic resection include patient insurance status and facility surgical volume
Annals of Pancreatic Cancer
2020;
3:
12
(15 October 2020)